New York Post3d
Stem cell therapy to correct heart failure in children could ‘transform lives’
Building on the work of Dr. Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells ... for this miracle therapy. Millions of children ...
RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead
Stem-cell research is on the cusp of a breakthrough that could come as soon as 2025, and two biotech companies with promising therapies stand to gain, according to a new report from Maxim Group on ...
Nature4y
First licensed stem cell therapy for ALS
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...
Nature12d
CRISPR genome-editing grows up: advanced therapies head for the clinic
Gene-editing technologies for cancer and blood disorders are maturing a little more than a year after the first CRISPR drug ...
Business Wire1mon
GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes.
SAN DIEGO--(BUSINESS WIRE)--Global Institute of Stem Cell Therapy and Research, Inc. known as GIOSTAR, a San Diego, California based Global organization at the forefront of stem cell research over ...
Fox News4d
Stem cell therapy to correct heart failure in children could 'transform lives'
Building on the work of Dr. Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells ... for this miracle therapy. Millions of children ...